Tabernanthalog

Modify Date: 2024-04-09 15:15:48

Tabernanthalog Structure
Tabernanthalog structure
Common Name Tabernanthalog
CAS Number 2483829-58-7 Molecular Weight 230.31
Density N/A Boiling Point N/A
Molecular Formula C14H18N2O Melting Point N/A
MSDS N/A Flash Point N/A

 Use of Tabernanthalog


Tabernanthalog is a water-soluble, non-hallucinogenic and non-toxic analogue of ibogaine. Tabernanthalog is a 5-HT2A agonist. Tabernanthalog is found to promote structural neural plasticity, reduce alcohol- and heroin-seeking behaviour, and produce antidepressant-like effects in rodents[1].

 Names

Name Tabernanthalog

 Tabernanthalog Biological Activity

Description Tabernanthalog is a water-soluble, non-hallucinogenic and non-toxic analogue of ibogaine. Tabernanthalog is a 5-HT2A agonist. Tabernanthalog is found to promote structural neural plasticity, reduce alcohol- and heroin-seeking behaviour, and produce antidepressant-like effects in rodents[1].
Related Catalog
Target

IC50: 148 μM (hERG channels expressed in HEK293 cells)[1]

In Vitro Tabernanthalog (0.1-100 μM) shows inhibition to hERG channels expressed in HEK293 cells with an IC50 value of 148 μM[1]. Tabernanthalog (0.001 nM-100 μM) demonstrats potent agonist activity for human and mouse 5-HT2A receptors[1].
In Vivo Tabernanthalog (10 and 50 mg/kg; i.p. once) shows no hallucinogenic effect in mouse head-twitch response assays[1]. Tabernanthalog (50 mg/kg; i.p. once) promotes structural neural plasticity in vivo[1]. Tabernanthalog (10 and 50 mg/kg; i.p. once) reduces the amount of time spent immobile after stress in a forced swim test of mice[1]. Tabernanthalog (50 mg/kg; i.p. once) selectively reduces alcohol intake[1]. Tabernanthalog (40 mg/kg; i.p. once) acutely reduces heroin-seeking behaviour in a rat model of heroin self-administration[1]. Animal Model: Male and female C57BL/6J mice[1] Dosage: 10 and 50 mg/kg Administration: Intraperitoneal injection; 10 and 50 mg/kg once Result: Showed nogenic potential in mouse head-twitch response assays. Animal Model: Anaesthetized male and female Thy1-GFP-M line mice with ketamine and xylazine injection[1] Dosage: 50 mg/kg Administration: Intraperitoneal injection; 50 mg/kg, once, after mice recovered from the anaesthesia of the first imaging session Result: Increased dendritic arbor complexity, dendritic spine density and spine formation but showed no effect on spine formation. Animal Model: Male C57/BL6J mice with alcohol-drinking for 7 weeks[1] Dosage: 50 mg/kg Administration: Intraperitoneal injection; 50 mg/kg, once, 3 h before the beginning of a drinking session Result: Reduced the alcohol consumption for at least 2 days after the administration.

 Chemical & Physical Properties

Molecular Formula C14H18N2O
Molecular Weight 230.31
Top Suppliers:I want be here

No recommended suppliers.

Hot Compounds More...
Dichloromethane
CAS#:75-09-2
Polyacrylic acid
CAS#:9003-01-4
sodium carbonate
CAS#:497-19-8
Silicon dioxide
CAS#:7631-86-9
Triethanolamine
CAS#:102-71-6
Demeton
CAS#:126-75-0
Water
CAS#:7732-18-5
4-(4-Piperidinyl)morpholine dihydrochloride
CAS#:53617-35-9
Diclofenac sodium
CAS#:15307-79-6
Budesonide
CAS#:51372-29-3